Skip to main content

Table 1 Antibodies used in this study

From: Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer—insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system

 

Antibody

Dilution

Supplier

Antigen

 Vimentin^,#

Mouse Monoclonal IgG (V9)

1:750

Dako, Australia

 E-cadherin^,#

Mouse Monoclonal IgG (36)

1:12,500

BD Transduction Laboratories, USA

 N-cadherin (A-CAM)

Mouse Monoclonal IgG (GC-4)

1:2000

Sigma-Aldrich, Australia

 TWIST^

Mouse/ 2C1a

1:100

Abcam, England

 Beta-catenin^

Mouse monoclonal, clone 14

1:500

BD Biosciences, Australia

 P120^

Mouse monoclonal 98/pp120

1:200

BD Biosciences, Australia

 CD24^

Mouse monoclonal SN3b

1:50

Thermo Fisher Scientific, Australia

 CD44^

Mouse monoclonal 156-3C11

1:75

Abcam, England

 Ki-67^

Mouse monoclonal MIB-1

1:100

Dako, Australia

 CA-IX^

Rabbit monoclonal

EP161

1:100

Cell Marque (Sigma Aldrich), USA

 ITGB1#

Mouse Monoclonal IgG

1:5000

Chemicon International (Fisher Scientific), USA

 ITGA2#

Rabbit Polyclonal

1:1000

Chemicon International (Fisher Scientific), USA

 Integrin-Linked Kinase (ILK)#

Rabbit monoclonal IgG

1:4500

Cell Signaling Technologies (Danvers, MA,USA)

 Pan-Actin, Ab-5#

Mouse Monoclonal IgG

1:10,000

Neomarkers (Invitrogen), USA

Secondary antigen

 Biotinylated Immunoglobulin^,#

Polyclonal Rabbit Anti-Mouse

1:200

Dako, Australia

 IgG-HRP^,#

Goat Anti-Mouse

1:20,000

Dako, Australia

 IgG-HRP^,#

Goat Anti-Rabbit

1:20,000

Dako, Australia

  1. ^Antibody used for IHC
  2. #Antibody used for WB